Next Article in Journal
The Role of Nucleotide Excision by Reverse Transcriptase in HIV Drug Resistance
Next Article in Special Issue
Lentiviral Vectors and Cystic Fibrosis Gene Therapy
Previous Article in Journal
Herpesviruses and Autophagy: Catch Me If You Can!
Previous Article in Special Issue
Virus Infection Recognition and Early Innate Responses to Non-Enveloped Viral Vectors
Article Menu

Export Article

Open AccessReview
Viruses 2010, 2(2), 334-371; doi:10.3390/v2020334

Development of Viral Vectors for Use in Cardiovascular Gene Therapy

Vascular Gene Therapy Unit, School of Biomedicine, Manchester Academic Health Science Centre, Room 3.26, Core Technology Facility, 46 Grafton Street, Manchester, M13 9NT, UK
Author to whom correspondence should be addressed.
Received: 14 December 2009 / Revised: 15 January 2010 / Accepted: 26 January 2010 / Published: 27 January 2010
(This article belongs to the Special Issue Novel Viral Vector Systems for Gene Therapy)
View Full-Text   |   Download PDF [348 KB, uploaded 12 May 2015]   |  


Cardiovascular disease represents the most common cause of mortality in the developed world but, despite two decades of promising pre-clinical research and numerous clinical trials, cardiovascular gene transfer has so far failed to demonstrate convincing benefits in the clinical setting. In this review we discuss the various targets which may be suitable for cardiovascular gene therapy and the viral vectors which have to date shown the most potential for clinical use. We conclude with a summary of the current state of clinical cardiovascular gene therapy and the key trials which are ongoing. View Full-Text
Keywords: cardiovascular gene therapy; adenovirus; adeno-associated virus; lentivirus cardiovascular gene therapy; adenovirus; adeno-associated virus; lentivirus

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Williams, P.D.; Ranjzad, P.; Kakar, S.J.; Kingston, P.A. Development of Viral Vectors for Use in Cardiovascular Gene Therapy. Viruses 2010, 2, 334-371.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top